Different drug delivery agents, including synthetic polymers, virus-based vectors, lipid-based vectors, and extracellular vesicles (EVs), have been explored previously.
Stanford inventors have devised a method of multiplexing droplet reactions to analyze and identify many reactions in parallel on a single microfluidic chip using off-the-shelf flow control and valving.